We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+11.34%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$302M
AUM Growth
+$83.5M
Cap. Flow
+$69.1M
Cap. Flow %
22.88%
Top 10 Hldgs %
15.66%
Holding
829
New
363
Increased
97
Reduced
44
Closed
323

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$10.7M
2
ACN icon
Accenture
ACN
+$6.03M
3
ADBE icon
Adobe
ADBE
+$5.83M
4
LMT icon
Lockheed Martin
LMT
+$2.67M
5
PGR icon
Progressive
PGR
+$2.43M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Financials 14.46%
3 Consumer Discretionary 12.43%
4 Healthcare 12.24%
5 Industrials 11.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYAM icon
376
Rayonier Advanced Materials
RYAM
$610M
$253K 0.08%
65,627
+48,798
+290% +$205K
RSG icon
377
Republic Services
RSG
$65.7B
$252K 0.08%
+1,022
New +$253K
FSK icon
378
FS KKR Capital
FSK
$3.44B
$251K 0.08%
12,095
-11,238
-48% -$229K
STEP icon
379
StepStone Group
STEP
$3.82B
$251K 0.08%
+4,517
New +$242K
OFIX icon
380
Orthofix Medical
OFIX
$419M
$250K 0.08%
+22,449
New +$278K
BY icon
381
Byline Bancorp
BY
$1.76B
$249K 0.08%
+9,308
New +$239K
NWN icon
382
Northwest Natural Holdings
NWN
$2.12B
$247K 0.08%
+6,213
New +$258K
AEVA
383
Aeva Technologies
AEVA
$1.86B
$246K 0.08%
+6,505
New +$98.9K
SMMT icon
384
Summit Therapeutics
SMMT
$11.1B
$245K 0.08%
+11,535
New +$263K
MAN icon
385
ManpowerGroup
MAN
$2.63B
$244K 0.08%
+6,044
New +$264K
AMPL icon
386
Amplitude
AMPL
$1.41B
$243K 0.08%
+19,636
New +$212K
OLN icon
387
Olin
OLN
$2.12B
$243K 0.08%
12,094
-45
-0.4% -$935
SLVM icon
388
Sylvamo
SLVM
$1.63B
$241K 0.08%
+4,802
New +$270K
COST icon
389
Costco
COST
$420B
$239K 0.08%
241
-80
-25% -$79.5K
UDMY
390
DELISTED
Udemy
UDMY
$238K 0.08%
+33,894
New +$234K
LOW icon
391
Lowe's Companies
LOW
$125B
$235K 0.08%
+1,060
New +$237K
CWT icon
392
California Water Service
CWT
$3.12B
$234K 0.08%
+5,156
New +$247K
CVBF icon
393
CVB Financial
CVBF
$3.99B
$233K 0.08%
+11,791
New +$220K
FOLD
394
DELISTED
Amicus Therapeutics
FOLD
$232K 0.08%
+40,520
New +$262K
JCI icon
395
Johnson Controls International
JCI
$92.2B
$232K 0.08%
+2,197
New +$202K
VSTS icon
396
Vestis
VSTS
$1.88B
$231K 0.08%
40,274
+24,613
+157% +$173K
AUPH icon
397
Aurinia Pharmaceuticals
AUPH
$2.11B
$227K 0.08%
+26,855
New +$215K
CART icon
398
Maplebear
CART
$11.8B
$227K 0.08%
+5,020
New +$218K
LTH icon
399
Life Time Group Holdings
LTH
$9.79B
$227K 0.08%
+7,474
New +$222K
SLB icon
400
SLB Ltd
SLB
$75B
$226K 0.08%
+6,699
New +$232K

Similar funds

Oxford Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Oxford Asset Management held 829 positions worth $302M, up 38% from $219M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oxford Asset Management deployed $69.1M of net new capital in Q2 2025, opening 363 new positions and adding to 97 existing holdings. Its largest new stake was Accenture: 19,786 shares worth $5.91M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Marvell Technology, an estimated $1.18M trimmed.

  • Oxford Asset Management's largest Q2 2025 buy was Accenture: 19,786 shares worth $5.91M.
  • Oxford Asset Management added most to State Street SPDR S&P Biotech ETF in Q2 2025, an estimated $10.7M increase.
  • Oxford Asset Management's biggest Q2 2025 reduction was Marvell Technology, cutting an estimated $1.18M.
  • Oxford Asset Management fully exited Meta Platforms (Facebook) in Q2 2025, selling an estimated $2.64M.
  • Oxford Asset Management's ten largest holdings make up 16% of its $302M portfolio in Q2 2025.
  • Oxford Asset Management opened 363 new positions and closed 323 in Q2 2025.
  • Oxford Asset Management's portfolio value rose 38% quarter-over-quarter to $302M.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.